19-0480
硫酸镁 七水合物
JIS special grade, ≥99.5%
别名:
泻盐
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
MgSO4 · 7H2O
化学文摘社编号:
分子量:
246.47
UNSPSC Code:
12352302
PubChem Substance ID:
EC Number:
231-298-2
MDL number:
Assay:
≥99.5%
Grade:
JIS special grade
Form:
fine crystals
InChI key
WRUGWIBCXHJTDG-UHFFFAOYSA-L
InChI
1S/Mg.H2O4S.7H2O/c;1-5(2,3)4;;;;;;;/h;(H2,1,2,3,4);7*1H2/q+2;;;;;;;;/p-2
SMILES string
O.O.O.O.O.O.O.[Mg++].[O-]S([O-])(=O)=O
grade
JIS special grade
vapor density
<0.01 (vs air)
assay
≥99.5%
form
fine crystals
availability
available only in Japan
pH
5.0-8.0 (50 g/L)
正在寻找类似产品? 访问 产品对比指南
存储类别
13 - Non Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
Ran D Goldman et al.
Pediatrics, 132(6), e1634-e1641 (2013-11-28)
Vaso-occlusive episodes (VOEs) are the most common complication of sickle cell disease in children. Treatment with magnesium seems to improve cellular hydration and may result in reduced vaso-occlusion. This study aimed to determine if intravenous (IV) magnesium sulfate (MgSO4) reduces
Oluwakemi Badaki-Makun et al.
Pediatric blood & cancer, 61(6), 1049-1054 (2014-01-21)
Multiple recent Sickle Cell Disease studies have been terminated due to poor enrollment. We developed methods to overcome past barriers and utilized these to study the efficacy and safety of intravenous magnesium for vaso-occlusive crisis (VOC). We describe the methods
E S Bain et al.
BJOG : an international journal of obstetrics and gynaecology, 121(5), 595-603 (2014-01-07)
To evaluate a slower (compared with a standard) infusion rate of the loading dose of magnesium sulphate for preterm fetal neuroprotection as a strategy to reduce maternal adverse effects. Randomised controlled trial. South Australian maternity hospital. Fifty-one women at <30
Chris Chin
Artificial organs, 37(1), 100-102 (2013-01-12)
Congenital heart disease (CHD) is relatively common and there are treatment options for virtually every form of CHD. With good care, the majority of babies can survive to adulthood; however, CHD remains a significant cause of death in infancy and
Karen J Gibbins et al.
Obstetrics and gynecology, 121(2 Pt 1), 235-240 (2013-01-25)
Clinical trials support the efficacy and safety of magnesium sulfate for cerebral palsy prevention. We evaluated the implementation of a clinical protocol for the use of magnesium for cerebral palsy prevention in our large women's hospital, focusing on uptake, indications
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持